Home » Topics » Regulatory

Regulatory
RSS

Suramin submitted for FDA approval for cancer indication

Jan. 30, 1998

Proleukin cleared for marketing in U.S. for melanoma indication

Jan. 30, 1998

Anesta signs European marketing agreement for Actiq

Jan. 29, 1998

New once-daily rosacea therapy introduced in U.S.

Jan. 27, 1998

Once-daily hair loss treatment available throughout the U.S.

Jan. 27, 1998

Botox compared to saline for chronic anal fissure

Jan. 22, 1998

Timentin cleared for pediatric use in U.S.

Jan. 22, 1998

Pfizer to develop Nastech formulation of sleep aid

Jan. 21, 1998

Controlled-release tramadol under development

Jan. 20, 1998

Sheffield proceeds with development of respiratory drugs in its MSI

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 11, 2025.
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld Asia
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty
BioWorld
With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...